Specifics of the issuer bid All common shares will be purchased under the Bid on the open market through the facilities of the CSE and payment for the common shares will be made in accordance with CSE policies. The price paid for the common shares will be the prevailing market price at the time of purchase and all common shares acquired by the Company will be cancelled. The Company has 53,764,820 common shares issued and outstanding as of July 31, 2018. Purchases may be suspended at any time, and no purchases will be made other than by means of open market transactions during the term of the Bid.
From the investor fact sheet
>80% Insider + Acquired Assets + Strategic Corporate (Aphria) + Family Ofce + Institutional ownership
PREVIOUS FINANCINGS:
t 04/15—10/15: C$2.1mm @C$0.50/share
t 03/16 :C$2.5mm @C$0.75/share
t 06/16—07/16: C$4.7mm @C$1.00/unit t 10/16 (RTO): C$5.0m @C$2.00/share
t 02/17: C$15mm bought deal financing @C$3.00/unit
t $7.46mm raised from the exercise of warrants
So there are insiders who are sitting on %1000. At the same time not a lot of additional dilution. The following does not reflect the most current state and is for reference only.
DILUTIVE SECURITIES:
t 4.10mm incentive RSUs issued and outstanding, including 1.88mm currently vested
t 0.85mm share options with exercise prices largely at $3.73 t 750,000 shares ($1.5mm convertible debt with Aphris Inc, convertible at $2/share)
t 0.57mm warrants exercisable at between $1.50-$3.00/share
t 2.37mm warrants exercisable at $4.50/share
53 million or outstanding, reduced by 5% will be down close to 50. Greater than 80% insider owned leaves about 10 million free floating shares available. Average trading volume of about 650 000. Today 350 000.
At any given time 3-5% of the free float is trading. This is a race to secure the biggest position possible. We as retail traders are lucky to be able to buy ahead of all major US institutions. If the company remains intact and grows to what Marc believes it will, once Federal law changes watch out. Can you imagine listing on the NASDAQ in 2019/20 with proven quarterly revenue in excess of $20 million?